問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2020-01-01 - 2026-06-30
Condition/Disease
Heavily Treatment Experienced People Living with HIV-1 Infection
Test Drug
Lenacapavir (LEN: previously referred to as GS-6207)
Participate Sites5Sites
Not yet recruiting3Sites
Recruiting2Sites
2025-05-01 - 2030-04-30
Extensive-stage small cell lung cancer (ES-SCLC)
sacituzumab govitecan
Participate Sites9Sites
Recruiting9Sites
2021-09-01 - 2025-08-31
Participate Sites4Sites
Terminated4Sites
2017-09-01 - 2023-12-29
Participate Sites2Sites
Terminated2Sites
2023-06-01 - 2025-12-31
Recruiting5Sites
2024-12-01 - 2028-12-31
2023-12-01 - 2026-12-31
2024-10-01 - 2026-12-31
Participate Sites6Sites
Not yet recruiting6Sites
2023-02-01 - 2025-12-31
Severe Hypertriglyceridemia
Olezarsen (ISIS 678354)
Participate Sites7Sites
Recruiting7Sites
2024-05-01 - 2032-12-31
全部
